Iron dextran and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Iron dextran (iron dextran) and Acyclovir (acyclovir). Common drug interactions include abscess neck among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Iron dextran and Acyclovir. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Iron dextran?

Iron dextran has active ingredients of iron dextran. It is often used in anemia. eHealthMe is studying from 1,487 Iron dextran users. Check the latest studies of Iron dextran.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.



On Jul, 30, 2026

18 people who take Iron dextran and Acyclovir together, and have interactions are studied.

Iron dextran and Acyclovir drug interactions.

What are the common drug interactions of Iron Dextran and Acyclovir, by gender? *:

female:

  1. Abscess neck (neck abscesses)
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cardiac failure congestive
  6. Decreased interest
  7. Deformity (disfigurement)
  8. Discomfort
  9. Emotional distress
  10. Gingival disorder (gum disease)

male:

  1. Anaemia (lack of blood)
  2. Dyspnoea (difficult or laboured respiration)
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial tachycardia (rhythm disturbance that arises in the atria)
  6. Atrioventricular block complete (heart block complete)
  7. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  8. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. Blood glucose increased

What are the common drug interactions of Iron Dextran and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Candidiasis (candidiasis or thrush is a fungal infection)
  3. Cardiac failure congestive
  4. Decreased interest
  5. Deformity (disfigurement)
  6. Dehydration (dryness resulting from the removal of water)
  7. Discomfort
  8. Emotional distress
  9. Fall
  10. Gingival disorder (gum disease)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Actinic elastosis (disorder in which the skin appears yellow and thickened as a result of sun damage)
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial tachycardia (rhythm disturbance that arises in the atria)
  6. Atrioventricular block complete (heart block complete)
  7. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  8. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. Blood glucose increased

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 66.67%
  2. Anaemia (lack of blood): 10 people, 55.56%
  3. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 10 people, 55.56%
  4. Chronic Renal Failure (kidney failure): 4 people, 22.22%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 5.56%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.56%
  7. Blood Triglycerides Decreased: 1 person, 5.56%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 5.56%
  9. Diarrhea: 1 person, 5.56%
  10. Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Iron dextran and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Iron dextran and Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Iron dextran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Iron dextran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on iron dextran and acyclovir (the active ingredients of Iron dextran and Acyclovir, respectively), and Iron dextran and Acyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: